3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
16
Neoplasms
9
Treatment of Venous Thromboembolism in Cancer Patients
3
Thrombosis
2
Pulmonary Embolism
2
Multiple Myeloma
2
Venous Thrombosis
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Prevention of Venous Thromboembolism
1
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
1
Ovarian Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Embolism
1
Dyskinesias
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
edoxaban
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Embolism
×
Rivaroxaban
×
Classical hematology
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled